Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enobosarm with GLP-1 agonists for muscle preservation in obesity
NCT06282458Phase 2Completed
- Sponsor
- Veru Inc.
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of enobosarm in Sarcopenia, sponsored by Veru Inc.. Started Apr 2024; status: completed.
02
Drugs
enobosarm
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on NCT06282458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06282458.